Home » Archive

Marketwire, News, Syndication »

Cytori Obtains Celution(R) Approval in Russia; To Launch Product Line for Plastic Surgery and Select Soft Tissue Therapies

Posted by Mary Canady May 30th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 30, 2012) – Cytori Therapeutics (NASDAQ: CYTX) has obtained approval to sell the Celution® 800 System in Russia for various medical uses. These clinical uses are based on those in the current European CE Mark, and i…

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

Posted by Mary Canady May 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 25, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) (the “Company” and “La Jolla”) held its 2012 Annual Meeting of Stockholders on May 22. All matters submitted to a vote of the stockholders …

More...

Marketwire, News, Syndication »

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

Posted by Mary Canady May 25th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 25, 2012) – La Jolla Pharmaceutical Company (OTCQB: LJPC) (PINKSHEETS: LJPC) (the “Company” and “La Jolla”) held its 2012 Annual Meeting of Stockholders on May 22. All matters submitted to a vote of the stockholders …

More...

Marketwire, News, Syndication »

Nokia Sensing X CHALLENGE — Searching the World for the Most Powerful Digital Health Sensors to Transform the Healthcare Industry

Posted by Mary Canady May 24th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 24, 2012) – The X PRIZE Foundation and Nokia today announced the launch of the Nokia Sensing X CHALLENGE, a $2.25 million global competition to stimulate the development of a new generation of health sensors and sens…

More...

Marketwire, News, Syndication »

True Diagnostics Receives CE Mark for TrueDX(TM) Platform & TSH Test

Posted by Mary Canady May 24th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 24, 2012) – True Diagnostics, Inc.T (www.TrueDiagnostics.com) has announced it has received a CE Mark to allow it to distribute its TrueDX Platform and quantitative TSH (Thyroid Stimulating Hormone) test in Europe. W…

More...

Marketwire, News, Syndication »

Cytori to Present at the Jefferies 2012 Global Healthcare Conference on June 5

Posted by Mary Canady May 23rd, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 23, 2012) – Cytori Therapeutics (NASDAQ: CYTX) will present and provide a corporate update from the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 10:00 AM ET.
The presentation will …

More...

Marketwire, News, Syndication »

Aegis Therapeutics Awarded Patent for Octreotide Formulations Suitable for Oral and Metered Nasal Spray Delivery

Posted by Mary Canady May 21st, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 21, 2012) – Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,133,863 providing broad protection for pharmaceutical composition of octreotide. The highly stable octreotide formulations…

More...

Marketwire, News, Syndication »

Second Parathyroid Hormone (PTH) Peptide Drug Patent Awarded to Aegis Therapeutics for Compositions Suitable for Metered Nasal Spray, Oral, and Injectable Delivery

Posted by Mary Canady May 16th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 16, 2012) – Aegis Therapeutics LLC announced today that it has been awarded a second patent, U.S. Patent, No. 8,173,594, providing PTH and PTH analog compositions having increased stability and reduced aggregation an…

More...

Marketwire, News, Syndication »

Cytori Provides Business Update; Reports First Quarter Results

Posted by Mary Canady May 9th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 9, 2012) – During the first quarter of 2012, Cytori Therapeutics (NASDAQ: CYTX) advanced its cardiac cell therapy product pipeline, grew the commercial business, and strengthened operational and financial performance…

More...

Marketwire, News, Syndication »

Bio-Matrix Scientific Group, Inc. Hires President for Its Regen BioPharma Subsidiary

Posted by Mary Canady May 8th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – May 8, 2012) – Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) (PINKSHEETS: BMSN) announced today that J. Christopher Mizer has joined the Company as President and Chief Operating Officer of its Regen BioPharma subsidiar…

More...